Yale Indian American Prof. Samit Shah Receives Naratil Pioneer Award, Leading Way to Improved Heart Disease Diagnosis in Women
Yale's Samit Shah is leading a team to demonstrate the effectiveness of validated, but not widely administered, procedures for the many women who have reduced blood flow to the heart without blocked arteries or cholesterol build-up often associated with heart disease.Source: India West
Improving the Diagnosis of Heart Disease in Women
Dr. Samit Shah is leading a team to demonstrate the effectiveness of validated, but not widely administered procedures for the many women who have reduced blood flow to the heart without blocked arteries or cholesterol build-up often associated with heart disease.
Assessing an Insomnia Intervention for Black Women
Dr. Soohyun Nam is testing — for the first time — an evidence-based stress-reduction intervention for insomnia that has shown potential for addressing the underlying causes of sleep difficulty in a manner culturally sensitive to the needs of Black women.
Pilot grants to study the health of women and resources for women faculty at Yale gaining momentum
Even today, attention to research on women’s health remains far behind that of men, and fewer women faculty are pursuing opportunities to commercialize their research. Two organizations at Yale – Women’s Health Research at Yale (WHRY) and the Office of Cooperative Research (OCR) --- are looking to change those trends, offering grants and programs specifically aimed at supporting women’s health research and supporting women faculty who wish to seek funding to bring their discoveries to a commercial light.
Sex-specific Immune Response in COVID-19 Linked to Cellular Metabolism
Researchers studying COVID-19 patients have found a metabolic pathway that is highly correlated with immune responses only in male patients, a group known to be more likely to suffer severe cases and die of the disease, representing a potential target for therapeutic intervention.Source: Yale News
In Female Veterans With Early ASCVD, Secondary Prevention Falls Short
Female veterans with premature atherosclerotic cardiovascular disease (ASCVD), as well as those with extremely premature disease onset, are much less likely to receive evidence-based medical therapy, including high-intensity statins, when compared with male veterans, a new Veterans Affairs (VA) study shows.Source: TCTMD